Overview

Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of PF 03187207.
Phase:
Phase 2
Details
Lead Sponsor:
Bausch & Lomb Incorporated
Collaborator:
NicOx Inc.
Treatments:
Latanoprost